MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04862cam a22004218i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
on1250260753 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240726104837.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
210510s2021 nyu ob 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2021018520 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DLC |
| Language of cataloging |
eng |
| Description conventions |
rda |
| Transcribing agency |
DLC |
| Modifying agency |
YDX |
| -- |
OCLCO |
| -- |
EBLCP |
| -- |
UKAHL |
| -- |
OCLCF |
| -- |
NT |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781536196146 |
| Qualifying information |
|
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
pcc |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
R728 |
| Item number |
.E266 2021 |
| 049 ## - LOCAL HOLDINGS (OCLC) |
|---|
| Holding library |
MAIN |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
The economics of diseases and cures /Randall Waechter, PhD, Associate Director of Research, Assistant Dean School of Graduate Studies, and Associate Professor School of Medicine, St. George's University, West Indies, editor. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 347 ## - DIGITAL FILE CHARACTERISTICS |
|---|
| File type |
data file |
| Source |
rda |
| 490 1# - SERIES STATEMENT |
|---|
| Series statement |
Economic Issues, Problems and Perspectives Ser. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographies and index. |
| 520 0# - SUMMARY, ETC. |
|---|
| Summary, etc. |
"This book examines the process of cure discovery and the economic impact of cures across varying diseases. It is the first time anyone has attempted to examine the [economic] returns across a wide spectrum of disease categories, using a common frame of reference"-- |
| Assigning source |
|
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Intro -- |
| Title |
Contents -- |
| -- |
Foreword -- |
| -- |
Acknowledgments -- |
| -- |
List of Acronyms -- |
| -- |
Section A. Background and Measures -- |
| -- |
Chapter 1 -- |
| -- |
The Economics of Diseases and Cures -- |
| -- |
Different Levels of Cures: Functional vs. Definitive -- |
| -- |
Measuring the Economic Impact of Cures: Cost Strategy vs. Cures Strategy -- |
| -- |
The Diffusion of Cures -- |
| -- |
The Value of Case Studies -- |
| -- |
References -- |
| -- |
Chapter 2 -- |
| -- |
Tools and Assumptions -- |
| -- |
Data Sources -- |
| -- |
Timelines -- |
| -- |
Disease Categorization -- |
| -- |
Cure Categorization -- |
| -- |
Measures used to Assess the Value of Cures -- |
| -- |
Years of Potential Life Lost (YPLL) -- |
| -- |
Quality-Adjusted Life Years (QALY) |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Disability-Adjusted Life Years (DALY) -- |
| Title |
Cure Impact -- |
| -- |
Calculation Assumptions -- |
| -- |
References -- |
| -- |
Section B. Infectious Diseases -- |
| -- |
Chapter 3 -- |
| -- |
Acquired Immunodeficiency Syndrome (AIDS/HIV) -- |
| -- |
Disease Category -- |
| -- |
Disease Identification, Description, and Diagnostic Criteria -- |
| -- |
Disease Etiology (Cause) -- |
| -- |
Current Prevalence/Incidence -- |
| -- |
Estimated Undiagnosed and At-Risk -- |
| -- |
Disease Impact -- |
| -- |
Years of Potential Life Lost (YPLL) -- |
| -- |
Disease Impact -- |
| -- |
Disability Adjusted Life Years (DALY) -- |
| -- |
History of the Disease and Breakthroughs -- |
| -- |
Current Cure Status -- |
| -- |
Future Cure Obstacles |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Research Development and Treatment Costs -- |
| Title |
HIV Cures: Anti-Retroviral Therapy (ART) -- |
| -- |
Cure Category -- |
| -- |
Cure Identification/Description -- |
| -- |
Cure History -- |
| -- |
Cure Science: Breakthroughs/Obstacles -- |
| -- |
Cure Science: Future Obstacles -- |
| -- |
Number of Patients Currently Being Treatment -- |
| -- |
Number of Patients Requiring Treatment -- |
| -- |
Impact of Treatment on Years of Potential Life Lost (YPLL) -- |
| -- |
Impact of Treatment on Disability-Adjusted Life Years (DALY/QALY) -- |
| -- |
Cost of Treatment Using ART per Patient -- |
| -- |
Cost of Lifetime Treatment Using ART -- |
| -- |
Economic Impact -- |
| -- |
Value of Life Added -- |
| -- |
HIV Cures -- |
| -- |
Vaccination |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Cure Category -- |
| Title |
Cure History -- |
| -- |
Cure Science/Cure Obstacles -- |
| -- |
Phase I Trials -- |
| -- |
Phase II Trials -- |
| -- |
Phase III Trials -- |
| -- |
References -- |
| -- |
Chapter 4 -- |
| -- |
Influenza -- |
| -- |
Disease Category -- |
| -- |
Disease Description, Diagnosis, and Background -- |
| -- |
Disease Etiology (Cause) -- |
| -- |
Current Prevalence/Incidence -- |
| -- |
Estimated Undiagnosed/At-Risk -- |
| -- |
Disease Impact -- |
| -- |
Years of Potential Life Lost (YPLL) -- |
| -- |
Disease Impact -- |
| -- |
Disability Adjusted Life Years (DALY) -- |
| -- |
History of the Disease and Breakthroughs -- |
| -- |
Current Cure Status -- |
| -- |
Research, Development and Treatment Costs -- |
| -- |
Influenza Cures: Vaccinations -- |
| -- |
Cure Category |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Cure Identification/Description -- |
| Title |
Cure History -- |
| -- |
Cure Science: Breakthroughs/Obstacles -- |
| -- |
Cure Science/Future Cure Obstacles and Targets -- |
| -- |
Number of Patients Currently Being Treated -- |
| -- |
Number of People Requiring Treatment -- |
| -- |
Impact of Treatment on Years of Potential Life Lost (YPLL) -- |
| -- |
Impact of Treatment on Disability-adjusted Life Years (DALY/QALY) -- |
| -- |
Average Annual Total/Lifetime Cost of Vaccinations -- |
| -- |
Economic Impact -- |
| -- |
Value of Life Added -- |
| -- |
Economic Impact -- |
| -- |
Value of Reduction in DALYs/Increase in QALYs -- |
| -- |
Influenza Cures: Antivirals -- |
| -- |
Cure Category -- |
| -- |
Cure Identification/Description |
| 530 ## - COPYRIGHT INFORMATION: |
|---|
| COPYRIGHT INFORMATION |
COPYRIGHT NOT covered - Click this link to request copyright permission: |
| Uniform Resource Identifier |
<a href="b">b</a> |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Medical economics. |
| 655 #1 - INDEX TERM--GENRE/FORM |
|---|
| Genre/form data or focus term |
Electronic Books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Waechter, Randall, |
| Relator term |
|
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| -- |
Click to access digital title | log in using your CIU ID number and my.ciu.edu password. |
| Uniform Resource Identifier |
<a href="httpss://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=2913941&site=eds-live&custid=s3260518">httpss://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=2913941&site=eds-live&custid=s3260518</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Online Book (LOGIN USING YOUR MY CIU LOGIN AND PASSWORD) |
| DONATED BY: |
|
| VENDOR |
EBSCO |
| Classification part |
R |
| PUBLICATION YEAR |
2021 |
| LOCATION |
ONLINE |
| REQUESTED BY: |
|
| -- |
|
| -- |
NFIC |
| Source of classification or shelving scheme |
|
| 994 ## - |
|---|
| -- |
92 |
| -- |
NT |
| 902 ## - LOCAL DATA ELEMENT B, LDB (RLIN) |
|---|
| a |
1 |
| b |
Cynthia Snell |
| c |
1 |
| d |
Cynthia Snell |